Conclusion Surgery remains the “gold standard” for operable early stage lung carcinoma in healthy patients. For early stage patients that may not be healthy enough to withstand the operation though, the CyberKnife® device is uniquely designed to deliver an ablative radiation dose to a moving cancer target in the chest, while preserving the maximum possible adjacent tissue, making it an ideal device to treat these patients.